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Summary: Activity of serum/plasma -N-acetylhexosaminidase (EC 3.2.1.52) was determined by means of a
continuous spectrophotometric method using 3,3'-dichlorophenylsulphonphthaleinyl-N-acetyl- -Z)-glucosaniinide as
substrate, with very satisfactory results. Incubation of an undiluted aliquot (1 ml) of samples at 52 °C for 8 hours
with an adjusted pH 5.5—6.0 provoked only the inactivation of isoenzyme A, thus allowing the evaluation of -JV-
acetylhexosaminidase isoenzyme composition. In 25 serum samples from control subjects and pregnant women, a
good correlation between the percentage of isoenzyme B obtained by this procedure and the fluorimetric assay of
O'Brien et al. (New Engl J Med 1970; 273:15-20) was found (r = 0.983, Syx = 1.51), with no statistically signifi-
cant difference between the means (43.2 vs 42.8%). In 84 healthy adult subjects, an average value of 30.3% for the
proportion of isoenzyme B was obtained, with an interval of 25.4—35.0%, in agreement with results reported by
other authors.
Introduction
The lysosomal enzyme -W-acetylhexosaminidase (EC
3.2.1.52)1) consists of two major isoenzymes, denoted
A and B. -Af-Acetylhexosaminidase A is a heterodimer
composed of α and β subunits, whereas -JV-acetylhex-
osaminidase Β is a homodimer solely comprised of β
subunits (1, 2). The so called intermediate forms ( -Af-
acetylhexosaminidase I), including P-form which
increase in serum during pregnancy, are post-transla-
tional modifications.
Until a few years ago, the almost exclusive clinical ap-
plication of -N-acetylhexosaminidase assay was the
biochemical diagnosis of gangliosidoses GM2 (Sand-
hojfs and Toy-Sachs diseases) and the detection of carri-
ers. However, more recent studies have revealed a devel-
oping interest in other physiopathological situations
(3 — 11). For the determination of the β-ΛΓ-acetylhexos-
aminidase isoenzymes, various electrophoretic, Chroma-
tographie and immunochemical techniques have been
proposed, although the traditional heat inactivation as-
says are still used more often due to their simplicity
(1). These methods are based on the varying stability of
isoenzymes A and B with increases in temperature. Un-
der conditions where the pH is 4.4, isoenzyme B is rela-
tively thermostable for a temperature of 50—55 °C,
whereas isoenzyme A is rapidly inactivated. In order to
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perform heat treatment of the samples a large dilution is
done with a citrate buffer, which requires a high analyti-
cal sensitivity of the assay for the measurement of en-
zyme activity. This is carried out using substrates de-
rived from 4-methylumbelliferone that become fluores-
cent chromophore when hydrolyzed by the enzyme. A
large number of synthetic substrates have been manufac-
tured which allow spectrophotometric determination of
-Af-acetylhexosaminidase activity (7, 12); however,
their lower analytical sensitivity makes it difficult to
adapt them to this particular type of differential heat
inactivation assay of β-ΛΓ-acetylhexosaminidase isoen-
zymes.
In the present study a heat inactivation procedure at
52 °C was developed that permitted the determination of
β-,/V-acetylhexosaminidase isoenzymes in serum/plasma
using a continuous spectrophotometric method adapted
to a centrifugal analyzer.
Materials and Methods
Catalytic activities of -JV-acetylhexosaminidase were measured
using 3,3'-dichlorophenylsulphonphthaleinyl-W-acetyl- -£>-gluco-
saminide as substrate (13) by means of the commercially available
reagent NAG Rate Test® from Shionogi and Col., Ltd. (Chuo-Ku,
Osaka, Japan). Activity determinations were performed in a Cobas
Bio centrifugal analyzer (Roche Diagnostics, Basel, Switzerland)
programmed as follows: Units U/l; Calculation factor 587 (see re-
sults section); Standard 1-3 Cone. 0; Limit 0; Temperature [Deg.
C] 37.0; Type of Analysis 2; Wavelength [nm] 575. Sample Vol-
ume [μΐ] 10; Diluent Volume [μΐ] 50; Reagent Volume [μΐ] 150;
Incubation Time [sec.] 0: Start Reagent Volume [μΐ] Ο; Time of
First Reading [sec.] 300; Time Interval [sec.] 30; Numbers of Read-
ings 10; Blanking Mode 1; Prontout Mode 2. For the preparation
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of the reagent solution, 8.2 ml of distilled water was added to each
bottle containing lyophilized synthetic substrate and buffer. Under
these conditions, the final concentration of the substrate in the reac-
tion mixture was the same as that specified in the instructions for
the manual procedure. The calculation factor was established re-
garding the enzyme activity of Precimat ß-NAG® and Precinorm
ß-NAG® standards (Boehringer Mannheim GmbH, Mannheim,
Germany) whose assigned values are calculated on the basis of the
molar absorptivity of the released chlorophenolred under standard-
ized conditions (14).
It must be pointed out that the enzyme activity found therefore for
the Stand NAG® control from Shionogi and Co., Ltd., was on
average 68% (n = 18) of the assigned value by the manufacturer.
This fact could be due to the assigned enzyme activity for this
control material occurring so that the continuous method using the
3,3 '-dichlorophenylsulphonphthaleinyl-JV-acetyl- ß-Z)-glucosamin-
ide substrate gave equivalent activity to that of the discontinuous
method using the substrate m-cresolsulphonphthaleinyl-7V-acetyl-ß-
D-glucosaminide (15). However, the results obtained by various
authors have demonstrated that the use of the substrate »z-cresolsul-
phonphthalernyl-Af-acetyl-ß-D-glucosaminide gives significantly
higher enzyme activity than when 3,3'-dichlorophenylsulphon-
phrnaleinyl-W-acetyl-ß-D-glucosaminide is used (16—18). Conse-
quently, if the Stand NAG® control is used then the programmed
calculation factor in the analyzer should be 863.
A pH-meter for biological fluids Radiometer model ABL-300 (Ra-
diometer, Copenhagen, Denmark) was used for determining the pH
of serum samples.
Statistical analysis of the data was carried out using the SPSS
package. To check for normality, skewness and kurtosis coeffi-
cients or the Shapiro-Wilk test were used, depending on the size
of the sample. The significance of difference between mean
values was evaluated by the Wilcoxon sign range test for match-
ing data and by the Mann-Whitney U test for unpaired data.
Normally distributed data were analyzed statistically by means
of Pearson's correlation coefficient, otherwise Spearman's coeffi-
cient was used. Linear regression analysis was performed using
the Passing-Bablok method. A p-value less than 0.05 was con-
sidered to be significant.
Results
When the 3,3'-dichlorophenylsulphonphthaleinyl-7V-ace-
tyl-ß-Z)-glucosaminide method was used to determine
the activity of ß-W-acetylnexosaminidase in urine, ex-
cluding the slight enzyme-inhibiting effect of urea, it did
not appear that other endogenous metabolites, such as
urobilinogen, bilirubin, haemoglobin or glucose could
seriously interfere (17, 19). However, it was necessary
to investigate the possible effect of elevated concentra-
tions of albumin and globulins so that this substrate
could be used for determining enzyme activity in serum
or plasma. To do this, different quantities of bovine al-
bumin (Ektachem Solution Bovine Serum Albumin®,
Johnson and Johnson Clinical Diagnostics Inc., Roches-
ter, USA) were added to different Precimat ß-NAG®
control vials belonging to the same lot. The results ob-
tained are presented in figure 1, showing that bovine
albumin produces an inhibitory effect on ß-JV-acetylhex-
osaminidase activity. Human albumin produced an anal-
ogous inhibition, since the addition of fresh serum sam-
ples from different patients, whose ß-JV-acetylhexosami-
nidase activity had been previously determined, pro-
vided equivalent results to those that would be expected
10 30 40 50
Albumin added [g/l]
60 70 80
Fig. 1 Inhibiting effect of bovine (·) and human (o) serum albu-
min on ß-JV-acetylhexosaminidase activity from bovine kidney
(Precimat ß-NAG®) using 3,3'-dichlorophenylsulphonphthaleinyl-
JV-acetyl-ß-£>-glucosaminide as substrate.
in function of its albumin concentration (fig. 1). There-
fore, it did not appear that globulins had any effect on
ß-JV-acetylhexosaminidase activity when 3,3'-dichloro-
phenylsulphonphthaleinyl-Af-acetyl-ß-D-glucosarmnide
was used as substrate. The inhibitory effect produced by
albumin was of a non-competitive type, as implied by
the Lineweaver-Burk plot obtained. The inhibition of al-
bumin on the ß-W-acetylhexosaminidase A (ref. A8527)
and ß-7V-acetylhexosaminidase P (ref. A9175) purified
human placental isoenzymes from Sigma Chemical Co.
(St. Louis, USA), and the ß-JV-acetylhexosaminidase
from bovine kidney (Precimat ß-NAG®) presents an
analogous magnitude.
Consequently, in order to determine ß-JV-acetylhexos-
aminidase in serum/plasma and in pleural or peritoneal
fluids, the enzyme activities obtained should be recalcul-
ated by means of the correction factors relevant to the
albumin concentration shown in table 1. In any case, a
Tab. 1 Correction factors for ß~./V-acetylhexosaminidase activity
in function of the sample albumin concentrations.
Albumin
(g/l)
0
4
8
12
16
20
24
28
32
36
40
44
48
52
56
60
Residual activity
(%)
100
98
97
95
94
92
91
89
88
86
85
84
83
81
81
80
Correction
factor
1.000
1.020
1.031
1.053
1.064
1.087
1.099
1.124
1.136
1.163
1.176
1.190
1.205
1.235
1.235
1.250
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calculation factor of 700 (587 X 1.192), corresponding
to an albumin concentration of 45 g/1, may be used in
the programmation of the analyzer for routine determi-
nation of serum ß-N-acetylhexosaminidase activity. The
inaccuracy resulting from this approximation would be
a maximum of 2.5% for serum albumin concentrations
included in the reference interval. In 35 serum samples
from patients with different liver diseases and with an
average albumin concentration of 36 g/1 (interval = 18—
51 g/1), the activities thus obtained gave an excellent
correlation against the individually corrected values for
the albumin concentration (r = 0.997, Syx = 0.45), with
no statistically significant difference between the means
(11.4U/lvs ll.OU/1).
The precision obtained in the determination of serum
ß-W-acetylnexosaminidase must be considered as very
good, as shown in table 2, where the enzyme activity
remained unaltered for at least 60 days in samples
frozen at —20 °C. In all cases, the coefficient of varia-
tion was less than the medically accepted value ac-
cording to the criteria of the College of American
Pathologists (20).
An excellent correlation was achieved between the en-
zyme activities in serum obtained by means of the con-
tinuous method using 3,3'-dichlorophenylsulphonphtha-
leinyl-W-acetyl-ß-ß-glucosaminide (CPR-NAG) and the
discontinuous method using 2-methoxy-4-(2'-nitrovi-
nyl)-phenyl-Af-acetyl-ß-£)-glucosaminide (MNP-NAG)
as substrate, also adapted to the Cobas Bio according to
the guidelines provided by the manufacturer of the rea-
gent (Praill, Price and Richardson Diagnostics Ltd.,
London, UK): CPR-NAG = 0.72 X MNP-NAG + 0.67
(n = 93, r = 0.977, Sy.x = 0.525). The correlation be-
tween serum ß-W-acetylhexosaminidase activities ob-
tained with 3,3'-dichlorophenylsulphonphthaleinyl-JV-
acetyl-ß-£)-glucosaminide (CPR-NAG) and a fluorimet-
ric method using 4-methylumbelliferyl-JV-acetyl-ß-Z)-
glucosaminide (4MU-NAG) as substrate was also excel-
lent: CPR-NAG = 0.29 X 4MU-NAG -0.09 (n = 25,
r = 0.995, Sy.x = 0.682).
Tab. 2 Study of precision in determining serum ß-Af-acetylhexos-
aminidase activity in the Cobas Bio analyzer.
Within-run precision Between-run precision
Serum 1
Serum 2
Serum 3
Precinorn*
Precimat*
n
21
21
21
21
21
Mean
(U/l)
7.1
14.9
36.2
5.2
52.1
SD
(U/l)
0.07
0.13
0.26
0.06
0.33
CV
(%)
0.99
0.87
0.72
1.15
0.63
n
21
21
21
15
18
Mean
(U/l)
7.4
14.6
38.1
5.3
53.2
SD
(U/l)
0.13
0.24
0.35
0.11
0.44
CV
(%)
1.78
1.64
0.92
2.08
0.83
20
15
10
5 10 15
ß-N-Acetylhexosaminidase activity (plasma) [U/l]
20
* Lyophilized control materials reconstituted with 1 ml of bovine
serum albumin solution 70 g/1.
Fig. 2 Correlation and regression between serum and plasma ß-
JV-acetylhexosaminidase activities using 3,3'-dichlorophenylsul-
phonphthaleinyl-W-acetyl-ß-D-glucosaminide as substrate
(n = 196, y = 1.16x + 0.78, r - 0.955, Sy.x = 0.456).
The possible effect of different anticoagulants on ß-Af-
acetylhexosaminidase activity was investigated by add-
ing 4 pools of sera to Vacutainer® tubes (Becton-Dickin-
son Vacutainer Systems, Rutherford, USA) to half the
volume of blood drawn into the tubes. No significant
change in enzyme activity was observed due to the lith-
ium heparinate, K3EDTA, sodium citrate or citrate-
dextrose (data not shown).
The parallel analysis of ß-7V-acetylhexosaminidase activ-
ities in serum and plasma (blood collected with
K3EDTA as anticoagulant) gave the results shown in fig-
ure 2, where values in serum were significantly higher
than in plasma (p < 0.001). This fact was not due to a
simple dilution effect produced by the anticoagulant, as
this was taken into account when calculating the activi-
ties in plasma. The difference between the means was
superior to the medically acceptable error according to
the criteria of the College of American Pathologists
(20). A highly significant correlation between the dif-
ference of serum/plasma activity and the platelet count
in blood was found, as shown in figure 3. This differ-
ence in activity also shows a statistically significant
correlation with the packed platelet volume and the
leukocyte count in blood (tab. 3). Nevertheless, since
the platelet and leukocyte counts showed a significant
correlation between themselves (r = 0.500, p < 0.001),
the partial correlation between the difference of serum/
plasma activity and the leukocyte count, keeping the
platelet count constant, did not reach statistical signifi-
cance (r = 0.180, NS).
In 187 sera from healthy adult subjects of both sexes, we
found a mean activity of 7.3 U/l (SEM = 0.09; interval
= 5.1-10.2 U/l) and in 114 plasma samples a mean
448 Perez and Tutor: Assay of ß-N-acetymexosaminidase isoenzymes
3
l 2
0 100 200 300 400 500 600 700 800 900
Platelet count [109/l]
Fig. 3 Correlation between the difference of serum/plasma ß-N-
acetylhexosaminidase activity and the platelet count (n = 196,
r = 0.756, p < 0.001).
activity of 5.4 U/l (SEM = 0.10; interval = 3.7-8.0
U/l), using 3,3'-dichlorophenylsulphonphthaleinyl_/V-
acetyl-ß-Z)-glucosaminide as substrate. In agreement
with other authors (21, 22) no significant difference was
found for the enzyme activity with regard to sex.
Since the heat inactivation of the enzymes is strongly
influenced by the protein concentration of the medium
(23), for the selective heat inactivation of isoenzyme
A in samples of undiluted native serum, a careful
optimization of the experimental conditions had to be
carried out. A study published in 1993 by Isaksson et
al. (24) was used as a starting point. In this work it
was pointed out that after the incubation of 5 serum
samples at 37 °C for 15 hours, more than 80% of
isoenzyme B remained and less than 10% of isoen-
zyme A, whose catalytic activity and antigenic proper-
ties were destroyed together.
The incubation of 11 native serum samples at 37 °C, in
aliquots of 1 ml in closed tubes, led to an inactivation
of ß-7V-acetylhexosaminidase which was stabilized after
12 hours, as shown in figure 4. Once separated from the
clot, the serum suffered an increase in pH due to a loss
of CO2 depending on the temperature and the empty
space remaining in the tube above the samples (25). The
rapid inactivation at room temperature of the serum acid
phosphatase was attributed to this increase in pH (25).
ß-7V-Acetylhexosaminidase in serum would appear to be
more stable, since its remains fairly active under these
conditions for a period of at least 24 hours (26, 27), a
fact which we have confirmed. However, at 37 °C, in
samples that reach pH =» 8.5, alkalinization could play
an important role in the inactivation of ß-TV-acetylhexos-
aminidase. As shown in figure 4, acidification with citric
acid of the serum samples to pH « 6.0 prevents the in-
activation of ß-A/-acetylhexosaminidase during incuba-
tion at 37 °C.
Subsequently, a systematic study of the pH effect of se-
rum samples on the heat inactivation of ß-N-acetylhex-
osaminidase was carried out, although in order to opti-
mize the operative methodology, incubation was per-
formed at 52 °C. This temperature was established as a
compromise value in view of the temperature interval
(50—55 °C) recommended by various authors for the
heat inactivation of isoenzyme A in diluted serum sam-
ples with a buffer (1, 26, 31, 36). According to O'Brien
et al. (26), temperatures lower than 48 °C lead to the
incomplete inactivation of isoenzyme A, whereas tem-
peratures higher than 52 °C produce a significant inacti-
vation of isoenzyme B. Residual activities in aliquots of
a sera pool adjusted to different pH values with citric
110 r pH 6.0
£- 100
I
. 1 . 1 .
10 15
Time [h]
Fig. 4 Stability of ß-./V-acetylhexosaminidase at 37 °C in 11 na-
tive (pH = 8.2) and acidified (pH =* 6.0) sera. The results are ex-
pressed as mean ± SD.
Tab. 3 Correlation between the difference of serum/plasma ß-N-acetylhexosaminidase activity and the
platelet and leukocyte counts (n = 196).
Range:
Serum/plasma difference (U/l)
Platelet count Packed platelet
volume
( 1 9 / / /I 1 \J / 1 1 \ /O 1
20.0-865.0 0.01-0.87
0.756 0.676
Leukocyte count
Total
(109/1)
1.2-31.0
0.384
Polymorpho-
nuclear
0.7-26.2
0.350
Mono-
nuclear
0.4-4.6
0.305
In all cases, a significant correlation for p < 0.001 was found.
and Tutor: Assay of ß-iV-acetylhexosaminidase isoenzymes 449
acid for different periods of incubation at 52 °C are
shown in figure 5. For the most acidic pH values (pH
4.8) and the most alkaline (pH 8.2) assayed, a complete
inactivation of ß-JV-acetylhexosaminidase was obtained
with an incubation of 2—4 hours. Different residual
activities were found for the intermediate pH values
studied, which were stabilized in every case at 8 hours
of heat treatment (fig. 5). Consequently, the pH effect
of the samples was systematically investigated in a sera
pool taken from healthy control subjects and from an-
other pool of pregnant women adjusted to different pH
values and subjected to an 8 hours incubation period at
52 °C. The results obtained are shown in figure 6. It can
be seen that the maximum residual activity for both sera
pools was obtained for the interval of pH 5.5—6.0.
Above and below these limit values a rapid fall in en-
zyme activity can be observed, mainly for more acidic
pH values, in which a plainly visible white protein pre-
cipitate was noted.
pH5.7
pH5.4
 9
pH6.2
8 12
Time [h]
16 20
Fig. 5 Time course for heat inactivation of ß-7V-acetylhexosami-
nidase at 52 °C in a pool of sera adjusted to different pH values.
60 r
Fig. 6 Inactivation of serum ß-JV-acetylhexosaminidase by heat
treatment at 52 °C for 8 hours in a control subjects sera pool (o)
and another one from pregnant women (·) adjusted to different
pH values.
Fig. 7 Time course for heat treatment at 52 °C and pH = 5.8 on
activity of ß-JV-acetylhexosaminidase A and P human placental iso-
enzymes.
Incubation at 52 °C and pH «= 5.8 of ß-N-acetylhexos-
aminidase A and P purified human placental isoen-
zymes, supplemented with bovine serum albumin 50 g/1,
lead to the results shown in figure 7. The residual activ-
ity after 8 hours of incubation was always more than
95% for ß-N-acetylhexosaminidase P, whilst for isoen-
zyme A it was about 10%. An electrophoretic study in
cellulose acetate showed that this commercial purified
isoenzyme A presents an additional fraction with mobil-
ity similar to isoenzyme B and which represents about
10% of the total activity. This would explain the residual
activity found in the heat inactivation assay. On the con-
trary, the purified ß-./V-acetylhexosaminidase P showed
a single homogeneous electrophoretic band with similar
migration to that of isoenzyme B.
The only difference between serum ß-7V-acetylhexos-
aminidase P and isoenzyme B seems to be that P-form
contains more sialic acid (28). Threehundred of a
neuraminidase (EC 3.2.1.18) solution from Vibrio cho-
lerae 1 kU/1 (Boehringer Mannheim GmbH), free of -
W-acetylhexosaminidase activity, were added to 1 ml of
different pH adjusted sera (pH «5.8) from healthy con-
trol subjects and pregnant women (n = 8) and, after be-
ing incubated at room temperature for 7—24 hours, the
respective assays of heat inactivation at 52 °C was car-
ried out. The desialylation of ß-N-acetylhexosaminidase
by the neuraminidase did not significantly modify the
residual activity values obtained (data not shown),
which suggests that P-form and isoenzyme B show anal-
ogous thermostability. The heat inactivation assay of iso-
enzyme A was carried out in 10 aliquots of 1 ml from a
sera pool adjusted to pH «= 5.8, giving a mean residual
activity of 53.7%, with a SD = 0.79 and therefore a
CV = 1.47%.
In 25 serum samples taken from control subjects and
pregnant women a mean value of 43.2% for the propor-
tion of isoenzyme B was obtained, by means of the heat
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inactivation procedure described, and of 42.8% by the
fluorimetric assay of O 'Brien et al. (26), showing a good
correlation between the values: 4MU-NAG = 0.96 X
CPR-NAG + 1.30 (r = 0.983, Sy.x = 1.51, p < 0.001).
Therefore, the heat treatment of native serum samples
adjusted to pH 5.5-6.0 and incubated at 52 °C for 8
hours permits the differential inactivation of isoenzymes
A and B. The addition of 11 of acetic acid at 20% to
1 ml of serum, or of a tablet containing 4 mg of citric
acid (Prostatic Acid Stabilizer Tablets®, Sigma Chemical
Co.) to 1.5 ml of serum, provided the samples with a
pH « 5.8, which is very suitable for the inactivation of
isoenzyme A under the conditions described. In the case
of women in their 5th—9th month of pregnancy, a suit-
able pH was obtained by adding 10 of acetic acid
at 20% to 1 ml of serum. This is possibly due to the
haemodilution which occurs over this period. The addi-
tion of acetic or citric acid to different serum samples
as described (n = 20) led to about 3% loss of enzyme
activity.
In a control group of 84 healthy adult subjects, isoen-
zyme A and activity in serum was determined using
the heat inactivation procedure described, leading to an
average value for the proportion of isoenzyme of
30.3% (SEM = 0.28%) with a reference interval of
25.4-35.0%.
Discussion
The above results demonstrate that ß-7V-acetylhexosami-
nidase activity in serum or plasma can be determined
rapidly and precisely using 3,3'-dichlorophenylsul-
phonphthalemyl-Af-acetyl-ß-Z)-glucosammide as sub-
strate. The albumin seemed to be able to bind with this
substrate, subsequently forming the ternary complex en-
zyme-inhibitor-substrate and hindering the formation of
the chromophore, which would be in agreement with the
type of non-competitive inhibition found. When using
2-methoxy-4-(2'-nitrovinyl)-phenyl-A^-acetyl-ß-£)-glu-
cosaminide as substrate, no significant inhibition of the
- ^-acetylhexosaminidase was noted, even using albu-
min concentrations of 70 g/1. The different molecular
structures of both substrates could explain why the 3,3'-
dichlorophenylsulphonphthaleinyl-N-acetyl-ß-Z)-glucos-
aminide, whose molecule includes three benzene rings,
is bound to the albumin, while the 2-methoxy-4-(2'-nit-
rovinyl)-phenyl-JV-acetyl-ß-Z)-glucosaminide, whose less
bulky molecule with only one benzene ring, would not
create a bond with this protein. In any case, this inhibi-
tion does not seem to be a serious drawback for the use
of 3,3'-dichlorophenylsulphonphthaleinyl-7V-acetyl-ß-Z)-
glucosaminide to determine the ß-7V-acetylhexosaminid-
ase in biological fluids with high concentrations of albu-
min such as serum or plasma.
As far as the difference in activity of the ß-N-acetylhex-
osaminidase in serum and plasma is concerned, and even
the possible effects of anticoagulants, the bibliographic
data are not conclusive. O'Brien et al. (27) andNatowicz
et al. (29) do not find significant differences between
enzyme activity in serum and plasma. On the other hand,
Suzuki et al. (30) and O'Brien (31) point out that ß-
N-acetylhexosaminidase would be inhibited by heparin,
which could explain the lower activity obtained in
plasma collected with this anticoagulant. However, ac-
cording to Lombardo et al. (32), heparin, citrate, oxalate
or EDTA would not affect per se ß-JV-acetylhexosami-
nidase activity, as our results have also shown. Likewise,
these authors find significantly higher ß-7V-acetylhexos-
aminidase activity in serum than in plasma, and suggest
that the release of enzyme from the platelets could occur
during coagulation. Recently, Emiliani et al. (33) have
demonstrated that stimulation with thrombin provokes a
release by platelets of ß-Af-acetylhexosaminidase and
other glycohydrolases.
We also found greater enzyme activity in serum than
in plasma, there being a highly significant correlation
between the difference in serum/plasma activity and the
platelet count (fig. 3), which clearly supports the hy-
pothesis suggested by Lombardo et al. (32). On the other
hand, the partial correlation study which was carried out
seems to indicate that no significant release of leukocyte
ß-jV-acetylhexosaminidase to serum takes place during
coagulation.
The procedure developed for the heat inactivation of iso-
enzyme A at 52 °C for 8 hours in specimens of serum
or plasma adjusted to pH 5.5—6.0, allows for the use of
spectrophotometric methods in the evaluation of the ß-
TV-acetylhexosaminidase isoenzyme composition. The
addition of acetic or citric acid to the serum samples, as
indicated in the results, produces a slight inactivation
of ß-JV-acetylhexosaminidase (approx. 3%) which must
be taken into account. Acetate shows a clear inhibitory
effect on ß-JV-acetylhexosaminidase (l, 34), however,
the low concentrations reached in the reaction mixture
under experimental conditions used here must be con-
sidered.
The study of heat inactivation using the procedure de-
scribed, carried out with the purified human placental ß-
JV-acetylhexosaminidase P, showed a residual activity of
more than 95% in every case. Regarding the residual
activity found in purified human placental isoenzyme A
(approx. 10%), it may be explained by contamination of
this preparation by isoenzyme B discovered electropho-
retically. The conversion of isoenzyme A to isoenzyme
B, by reordering the subunits in the purified tissue
forms, is well documented in literature (1, 35).
The substrate 3-methylumbelliferyl-7V-acetyl-ß-Z)-glu-
cosaminide is commonly used in laboratories interested
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in the study of ß-W-acetylhexosaminidase isoenzymes,
as it offers suitable sensitivity due to the chromophore
released by the enzymatic action being fluorogenic.
However, fluorimetric methods require dedicated equip-
ment, and the low solubility of 4-methylumbelliferyl-./V-
acetyl-ß-Z)-glucosaminide and its instability in solution,
as well as problems in interlaboratory standardization (7,
12) should also be considered as possible drawbacks. It
is in this aspect that spectrophotometric methods could
offer certain advantages, and could be used in the eval-
uation of the ß-N-acetylhexosaminidase isoenzyme
composition in serum or plasma using the procedure de-
scribed here for the heat inactivation of isoenzyme A.
The values obtained for the proportion of isoenzymes A
and B in 84 healthy adult subjects of both sexes are
analogous to those given by other authors using different
analytical methods (5, 24, 35-37).
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